129 related articles for article (PubMed ID: 37017641)
1. CXC Chemokine Receptor Type 4 Antagonistic Gold Nanorods Induce Specific Immune Responses and Long-Term Immune Memory to Combat Triple-Negative Breast Cancer.
Meng Y; Zhou J; Liu X; Zeng F; Wen T; Meng J; Liu J; Xu H
ACS Appl Mater Interfaces; 2023 Apr; 15(15):18734-18746. PubMed ID: 37017641
[TBL] [Abstract][Full Text] [Related]
2. Optimization of endothelial growth factor receptor monoclonal antibody-gold nanorods photothermal therapy for laryngeal squamous cell carcinoma.
Hai Y; Wang H; Qiu Y; Huang R; Zhao L; Xu H; Dong Z; Zhang L; Sun W; Zhang S
Bioengineered; 2022 Feb; 13(2):3262-3274. PubMed ID: 35067164
[TBL] [Abstract][Full Text] [Related]
3. CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner.
Gibbs C; So JY; Ahad A; Michalowski AM; Son DS; Li Y
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012586
[TBL] [Abstract][Full Text] [Related]
4. PolyTLR7/8a-conjugated, antigen-trapping gold nanorods elicit anticancer immunity against abscopal tumors by photothermal therapy-induced in situ vaccination.
Liu X; Su Q; Song H; Shi X; Zhang Y; Zhang C; Huang P; Dong A; Kong D; Wang W
Biomaterials; 2021 Aug; 275():120921. PubMed ID: 34139508
[TBL] [Abstract][Full Text] [Related]
5. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
[TBL] [Abstract][Full Text] [Related]
6. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
7. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway.
Wen H; Zhong Y; Yin Y; Qin K; Yang L; Li D; Yu W; Yang C; Deng Z; Hong K
Int J Biol Sci; 2022; 18(7):2898-2913. PubMed ID: 35541893
[TBL] [Abstract][Full Text] [Related]
8. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer.
Gao M; Wang T; Ji L; Bai S; Tian L; Song H
Front Immunol; 2020; 11():366. PubMed ID: 32194569
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
Zhang M; Kim HS; Jin T; Moon WK
J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
[TBL] [Abstract][Full Text] [Related]
10. Heat-Confined Tumor-Docking Reversible Thermogel Potentiates Systemic Antitumor Immune Response During Near-Infrared Photothermal Ablation in Triple-Negative Breast Cancer.
Revuri V; Rajendrakumar SK; Park MS; Mohapatra A; Uthaman S; Mondal J; Bae WK; Park IK; Lee YK
Adv Healthc Mater; 2021 Nov; 10(21):e2100907. PubMed ID: 34541833
[TBL] [Abstract][Full Text] [Related]
11. Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer.
Yang Z; Liu T; Xie Y; Sun Z; Liu H; Lin J; Liu C; Mao ZW; Nie S
Acta Biomater; 2015 Oct; 25():194-204. PubMed ID: 26193000
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulator-Mediated Suppressive Tumor Immune Microenvironment Remodeling Nanoplatform for Enhanced Immuno/Chemo/Photothermal Combination Therapy of Triple Negative Breast Cancer.
Wang A; Yang X; Li R; Shao L; Zhao W; Hu X; Fang K; Chai K; Shi S; Dong C
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53318-53332. PubMed ID: 37943829
[TBL] [Abstract][Full Text] [Related]
13. Small gold nanorods-loaded hybrid albumin nanoparticles with high photothermal efficacy for tumor ablation.
Seo B; Lim K; Kim SS; Oh KT; Lee ES; Choi HG; Shin BS; Youn YS
Colloids Surf B Biointerfaces; 2019 Jul; 179():340-351. PubMed ID: 30991214
[TBL] [Abstract][Full Text] [Related]
14. Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages.
Emami F; Pathak S; Nguyen TT; Shrestha P; Maharjan S; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Jan; 329():645-664. PubMed ID: 33022330
[TBL] [Abstract][Full Text] [Related]
15. Targeting CXCL12-CXCR4 Signaling Enhances Immune Checkpoint Blockade Therapy Against Triple Negative Breast Cancer.
Lu G; Qiu Y; Su X
Eur J Pharm Sci; 2021 Feb; 157():105606. PubMed ID: 33131745
[TBL] [Abstract][Full Text] [Related]
16. Preventing Metastasis Using Gold Nanorod-Assisted Plasmonic Photothermal Therapy in Xenograft Mice.
Ali MRK; Warner PE; Yu AM; Tong M; Han T; Tang Y
Bioconjug Chem; 2022 Dec; 33(12):2320-2331. PubMed ID: 35156818
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Obr AE; Kumar S; Chang YJ; Bulatowicz JJ; Barnes BJ; Birge RB; Lazzarino DA; Gallagher E; LeRoith D; Wood TL
Breast Cancer Res; 2018 Nov; 20(1):138. PubMed ID: 30458886
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
19. Photothermal therapy with AuNRs and EGFRmAb-AuNRs inhibits subcutaneous transplantable hypopharyngeal tumors in nude mice.
Zhang Y; He J; Wang Y; Wen J; Zou Y; Yang Z; He X
Int J Oncol; 2018 Dec; 53(6):2647-2658. PubMed ID: 30221691
[TBL] [Abstract][Full Text] [Related]
20. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]